Setmelanotide
Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients
Rhythm · Phase 1/2 · Completed · Enrollment 99
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Setmelanotide Once Daily | n/r | n/r | n/r | n/r | n/r |
| Setmelanotide Split Dose | n/r | n/r | n/r | n/r | n/r |
| Placebo | 0 participants | 0 participants | 0 participants | n/r | 0 |
A count stays a count. This page does not turn a count into a percent.